| COVID-19-related cognitive dysfunction may be associated with transient disruption in the DLPFC glutamatergic pathway UH Yesilkaya, M Sen, YH Balcioglu Journal of Clinical Neuroscience 87, 153-155, 2021 | 30 | 2021 |
| A novel adverse effect of the BNT162b2 mRNA vaccine: First episode of acute mania with psychotic features UH Yesilkaya, M Sen, BG Tasdemir Brain, behavior, & immunity-health 18, 2021 | 25 | 2021 |
| SARS-CoV-2-associated first episode of acute mania with psychotic features M Sen, UH Yesilkaya, YH Balcioglu Journal of Clinical Neuroscience 87, 29-31, 2021 | 25 | 2021 |
| New variants and new symptoms in COVID-19: First episode psychosis and Cotard's Syndrome two months after infection with the B. 1.1. 7 variant of coronavirus UH Yesilkaya, M Sen, N Karamustafalioglu Schizophrenia Research 243, 315, 2022 | 18 | 2022 |
| Evaluation of IGF-1 as a novel theranostic biomarker for schizophrenia UH Yesilkaya, S Gica, MC Ilnem, M Sen, D Ipekcioglu Journal of Psychiatric Research 140, 172-179, 2021 | 10 | 2021 |
| Psychotic agitation in a patient with COVID-19: pathogenesis or iatrogenesis? UH Yesilkaya, YH Balcioglu, M Sen Psychiatry and Clinical Psychopharmacology 31 (2), 238, 2021 | 2 | 2021 |
| Temperament and character relations in borderline personality disorder GG Yilmaz, M Sen, SL Dönmezler, H Erensoy, TD Berkol The Journal of Neurobehavioral Sciences 8 (2), 89-95, 2021 | 1 | 2021 |
| Escitalopram-Associated Recurrent Sinusitis: A Case Report UH Yesilkaya, M Sen Journal of Clinical Psychopharmacology 41 (3), 347-349, 2021 | 1 | 2021 |
| Evaluation of the Correlation Between Peripheral Inflammatory Markers and Suicide Risk in Drug-Naive First-Episode Schizophrenia. ÜH Yeşilkaya, M Şen, YH Balcıoğlu, H Gökçay, P Çelikkıran, SK Balcıoğlu, ... Noro Psikiyatri Arsivi 67 (3), 275-280, 2024 | | 2024 |
| Evaluating the relationship between blood lipids, cardiac risk index, and suicidal behaviors in first-episode psychosis L Güçlü, M Şen, YH Balcıoğlu, P Çelikkıran, SSK Balcıoğlu, H Gökçay, ... European Psychiatry 67 (S1), S290-S290, 2024 | | 2024 |
| Enlarged basal ganglia in drug-naïve patients with first-episode psychosis immediately upon symptom onset ÜH Yeşilkaya, M Şen, N Yüzbaşıoğlu, KB Pençe, N Karamustafalioğlu Dusunen Adam-The Journal of Psychiatry and Neurological Sciences, 2024 | | 2024 |
| An Egg & Chicken Paradox: Are changes in the Basal ganglia volume the reason for or the result of Schizophrenia? M Sen, N Yuzbasıoglu, K PENÇE, N Karamustafalioglu Authorea Preprints, 2023 | | 2023 |
| A Rare Clinical Finding Associated With Very Low–Dose Clozapine: Pisa Syndrome M Sen, UH Yesilkaya, DT Berkol American Journal of Therapeutics 29 (6), e665-e667, 2022 | | 2022 |
| P. 0759 Peripheral pro-inflammatory marker signature in patients with first-episode psychosis SSK Balcioglu, UH Yesilkaya, YH Balcioglu, M Sen European Neuropsychopharmacology 53, S552-S553, 2021 | | 2021 |
| P. 0761 Current suicidal behavior in first-episode psychosis: may inflammatory markers discriminate from non-psychotic suicides? M Sen, UH Yesilkaya, YH Balcioglu, P Celikkiran, SSK Balcioglu, ... European Neuropsychopharmacology 53, S554-S555, 2021 | | 2021 |
| P. 0474 New variants, new symptoms in COVID-19: first episode psychosis and cotard's syndrome after infection with the B. 1.1. 7 variant of coronavirus M Sen, UH Yesilkaya, N Karamustafalioglu European Neuropsychopharmacology 53, S349, 2021 | | 2021 |
| A Case With Sexual Dysfunction Improved By Vortioxetine Dose Reduction and Sensate Focus Exercises SL Dönmezler, M Sen, MH Yildirim The Journal of Neurobehavioral Sciences 8 (1), 78-80, 2021 | | 2021 |
